BCT-100

pegylated human recombinant arginase · Bio-Cancer Treatment International Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BCT-100, covering 2012-03-14 to 2012-03-14. Get the full timeline:

Most recent: Clinical Trial Update: Study of Pegylated Human Recombinant Arginase for Liver Cancer (BCT-100-002) [Phase 1, Phase 2]